UPDATE: Piper Jaffray Raises PT on TranS1 to $6 (TSON)

Piper Jaffray is out with its report today on TranS1 TSON, raising its PT from $4.00 to $6.00. In a note to clients, Piper Jaffray writes, "We reiterate our Overweight rating and are increasing our PT to $6, based on 4.0x (prev. 2.5x) EV/2012E sales of $21.8 million. We are raising our target multiple to 4.0x, from 2.5x, based on improving valuation and sentiment over the next 12 months driven by the prospect of improving payor coverage. We expect sentiment to improve before we see an increase in revenues from additional insurance coverage." Shares of TSON closed Thursday at $4.63.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareHealth Care SuppliesPiper Jaffraytrans1
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!